<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biomedcentral.com/feeds/latestarticles/journal?journal=bmcmusculoskeletdisord&amp;quantity=&amp;format=rss&amp;version=">
        <title>BMC Musculoskeletal Disorders - Latest Articles</title>
        <link>http://www.biomedcentral.com/bmcmusculoskeletdisord/</link>
        <description>The latest research articles published by BMC Musculoskeletal Disorders</description>
        <dc:date>2009-07-10T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/10/83" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/10/82" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/10/81" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/10/80" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/10/79" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/10/78" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/10/77" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/10/76" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/10/75" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2474/10/74" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/10/83">
        <title>Pulsed electromagnetic fields after arthroscopic treatment for osteochondral defects of the talus: double-blind randomized controlled multicenter trial </title>
        <description>Background:
Osteochondral talar defects usually affect athletic patients. The primary surgical treatment consists of arthroscopic debridement and microfracturing. Although this is mostly successful, early sport resumption is difficult to achieve, and it can take up to one year to obtain clinical improvement. Pulsed electromagnetic fields (PEMFs) may be effective for talar defects after arthroscopic treatment by promoting tissue healing, suppressing inflammation, and relieving pain. We hypothesize that PEMF-treatment compared to sham-treatment after arthroscopy will lead to earlier resumption of sports, and aim at 25% increase in patients that resume sports.
Methods:
A prospective, double-blind, randomized, placebo-controlled trial (RCT) will be conducted in five centers throughout the Netherlands and Belgium. 68 patients will be randomized to either active PEMF-treatment or sham-treatment for 60 days, four hours daily. They will be followed-up for one year. The combined primary outcome measures are (a) the percentage of patients that resume and maintain sports, and (b) the time to resumption of sports, defined by the Ankle Activity Score. Secondary outcome measures include resumption of work, subjective and objective scoring systems (American Orthopaedic Foot and Ankle Society - Ankle-Hindfoot Scale, Foot Ankle Outcome Score, Numeric Rating Scales of pain and satisfaction, EuroQol-5D), and computed tomography. Time to resumption of sports will be analyzed using Kaplan-Meier curves and log-rank tests.DiscussionThis trial will provide level-1 evidence on the effectiveness of PEMFs in the management of osteochondral ankle lesions after arthroscopy.Trial registrationNetherlands Trial Register (NTR1636)</description>
        <link>http://www.biomedcentral.com/1471-2474/10/83</link>
                <dc:creator>Christiaan van Bergen</dc:creator>
                <dc:creator>Leendert Blankevoort</dc:creator>
                <dc:creator>Rob de Haan</dc:creator>
                <dc:creator>Inger Sierevelt</dc:creator>
                <dc:creator>Duncan Meuffels</dc:creator>
                <dc:creator>Pieter d'Hooghe</dc:creator>
                <dc:creator>Rover Krips</dc:creator>
                <dc:creator>Geert van Damme</dc:creator>
                <dc:creator>C. van Dijk</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2009, 10:83</dc:source>
        <dc:date>2009-07-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-10-83</dc:identifier>
        <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>83</prism:startingPage>
        <prism:publicationDate>2009-07-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/10/82">
        <title>Postural changes in women with chronic pelvic pain: a case control study</title>
        <description>Background:
Chronic pelvic pain (CPP) is a lower abdominal pain lasting at least 6 months, occurring continuously or intermittently and not associated exclusively with menstruation or intercourse. Although the musculoskeletal system has been found to be involved in CPP, few studies have assessed the contribution of posture in women with CPP. We therefore determined the frequency of postural changes in women with CPP.
Methods:
A case-control study included 108 women with CPP of more than  6 months&apos; duration (CPP group) who consecutively attended at the Hospital of the University of Sao Paulo and 48 healthy female volunteers (control group). Postural assessment was noninvasive and performed in the standing position, with the reference points of Kendall used as normal parameters. Factors associated with CPP were assessed by logistic regression analysis.
Results:
Logistic regression showed that the independent factors associated with CPP were postural changes in the cervical spine (OR 4.1; 95% CI 1.6-10.7; p &lt;0.01) and scapulae (OR 2.9; 95% CI 1.1-7.6; p &lt;0.05).
Conclusions:
Musculoskeletal changes were associated with CPP in 34% of women. These findings suggest that a more detailed assessment of women with CPP is necessary for better diagnosis and for more effective treatment.</description>
        <link>http://www.biomedcentral.com/1471-2474/10/82</link>
                <dc:creator>Mary Montenegro</dc:creator>
                <dc:creator>Elaine Mateus- Vasconcelos</dc:creator>
                <dc:creator>Julio Rosa e Silva</dc:creator>
                <dc:creator>Francisco Candido dos Reis</dc:creator>
                <dc:creator>Antonio Nogueira</dc:creator>
                <dc:creator>Omero Poli Neto</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2009, 10:82</dc:source>
        <dc:date>2009-07-07T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-10-82</dc:identifier>
        <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>82</prism:startingPage>
        <prism:publicationDate>2009-07-07T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/10/81">
        <title>Characteristics and natural course of vertebral endplate signal (Modic) changes in the Danish general population </title>
        <description>Background:
Vertebral endplate signal changes (VESC) are more common among patients with low back pain (LBP) and/or sciatica than in people who are not seeking care for back pain. The distribution and characteristics of VESC have been described in people from clinical and non-clinical populations. However, while the clinical course of VESC has been studied in patients, the natural course in the general population has not been reported. The objectives of this prospective observational study were to describe: 1) the distribution and characteristics of VESC in the lumbar spine, 2) its association with disc degeneration, and 3) its natural course from 40 to 44 years of age.
Methods:
Three-hundred-and-forty-four individuals (161 men and 183 women) sampled from the Danish general population had MRI at the age of 40 and again at the age of 44. The following MRI findings were evaluated using standardised evaluation protocols: type, location, and size of VESC, disc signal, and disc height. Characteristics and distribution of VESC were analysed by frequency tables. The association between VESC and disc degeneration was analysed by logistic regression analysis. The change in type and size of VESC was analysed by cross-tabulations of variables obtained at age 40 and 44 and tested using McNemar&apos;s test of symmetry.
Results:
Two-thirds (67%) of VESC found in this study were located in the lower part of the spine (L4-S1). VESC located at disc levels L1-L3 were generally small and located only in the anterior part of the vertebra, whereas those located at disc levels L4-S1 were more likely to extend further into the vertebra and along the endplate. Moreover, the more the VESC extended into the vertebra, the more likely it was that the adjacent disc was degenerated. The prevalence of endplate levels with VESC increased significantly from 6% to 9% from age 40 to 44. Again, VESC that was only observed in the endplate was more likely to come and go over the four-year period compared with those which extended further into the vertebra, where it generally persisted.
Conclusions:
The prevalence of VESC increased significantly over the four-year period. Furthermore, the results from this study indicate that the distribution of VESC, its association with disc degeneration and its natural course, is dependent on the size of the signal changes.</description>
        <link>http://www.biomedcentral.com/1471-2474/10/81</link>
                <dc:creator>Tue Jensen</dc:creator>
                <dc:creator>Tom Bendix</dc:creator>
                <dc:creator>Joan Sorensen</dc:creator>
                <dc:creator>Claus Manniche</dc:creator>
                <dc:creator>Lars Korsholm</dc:creator>
                <dc:creator>Per Kjaer</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2009, 10:81</dc:source>
        <dc:date>2009-07-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-10-81</dc:identifier>
        <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>81</prism:startingPage>
        <prism:publicationDate>2009-07-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/10/80">
        <title>Is health related quality of life associated with the risk of low-energy wrist fracture? A case control study.</title>
        <description>Background:
Some risk factors for low-energy wrist fracture have been identified. However, self-reported measures such as health-related quality of life (HRQOL) have not been examined as potential risk factors for wrist fracture. The aims of this study were to compare HRQOL prior to a low-energy wrist fracture in elderly patients (aged 50 years and older) with HRQOL in age- and sex-matched controls, and to explore the association between HRQOL and wrist fracture after adjusting for known risk factors for fracture such as age, weight, osteoporosis and falls.
Methods:
Patients with a low-energy wrist fracture (n = 181) and age- and sex-matched controls (n = 181) were studied. Shortly after fracture (median 10 days), patients assessed their HRQOL before fracture using the Short Form-36 (SF-36). Statistical tests included t tests and multivariate logistic regression analysis.
Results:
Several dimensions of HRQOL were significantly associated with wrist fracture. The direction of the associations with wrist fracture varied between the different sub-dimensions of the SF-36. After controlling for demographic and clinical variables, higher scores on general health (odds ratio (OR) = 1.31, 95 confidence interval (CI) = 1.10-1.56), bodily pain (OR = 1.18, 95 CI = 1.03-1.34) and mental health (OR = 1.39, 95 CI = 1.09-1.79) were related to an increased chance of being a wrist fracture patient rather than a control. In contrast, higher scores on physical role limitation (OR = 0.87, 95 CI = 0.79-0.95) and social function (OR = 0.65, 95 CI 0.53-0.80) decreased this chance. Significant associations with wrist fracture were also found for living alone (OR = 1.91, 95 CI 1.07-3.4), low body mass index (BMI) (OR = 0.92, 95 CI 0.86-0.98), osteoporosis (OR = 3.30, 95 CI 1.67-6.50) and previous falls (OR = 2.01, 95 CI 1.16-3.49).
Conclusion:
Wrist fracture patients perceive themselves to be as healthy as the controls before fracture. Our data indicate that patients with favourable and unfavourable HRQOL measures may be at increased risk of wrist fracture.</description>
        <link>http://www.biomedcentral.com/1471-2474/10/80</link>
                <dc:creator>Gudrun Rohde</dc:creator>
                <dc:creator>Anne Mengshoel</dc:creator>
                <dc:creator>Astrid Wahl</dc:creator>
                <dc:creator>Torbjorn Moum</dc:creator>
                <dc:creator>Glenn Haugeberg</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2009, 10:80</dc:source>
        <dc:date>2009-07-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-10-80</dc:identifier>
        <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>80</prism:startingPage>
        <prism:publicationDate>2009-07-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/10/79">
        <title>A walking programme and a supervised exercise class versus usual physiotherapy for chronic low back pain: a single-blinded randomised controlled trial. (The Supervised Walking In comparison to Fitness Training for Back Pain (SWIFT) Trial).</title>
        <description>Background:
Chronic low back pain (CLBP) is a persistent disabling condition with rising significant healthcare, social and economic costs. Current research supports the use of exercise-based treatment approaches that encourage people with CLBP to assume a physically active role in their recovery. While international clinical guidelines and systematic reviews for CLBP support supervised group exercise as an attractive first-line option for treating large numbers of CLBP patients at low cost, barriers to their delivery include space and time restrictions in healthcare settings and poor patient attendance. The European Clinical Guidelines have identified the need for research in the use of brief/minimal contact self-activation interventions that encourage participation in physical activity for CLBP. Walking may be an ideally suited form of individualized exercise prescription as it is easy to do, requires no special skills or facilities, and is achievable by virtually all ages with little risk of injury, but its effectiveness for LBP is unproven.Methods and design: This study will be an assessor-blinded randomized controlled trial that will investigate the difference in clinical effectiveness and costs of an individualized walking programme and a supervised general exercise programme compared to usual physiotherapy, which will act as the control group, in people with chronic low back pain. A sample of 246 patients will be recruited in Dublin, Ireland through acute general hospital outpatient physiotherapy departments that provide treatment for people with CLBP. Patients will be randomly allocated to one of the three groups in a concealed manner. The main outcomes will be functional disability, pain, quality of life, fear avoidance, back beliefs, physical activity, satisfaction and costs, which will be evaluated at baseline, and 3, 6 and 12 months [follow-up by pre-paid postage]. Qualitative telephone interviews and focus groups will be embedded in the research design to obtain feedback about participants&apos; experiences of the interventions and trial participation, and to inform interpretation of the quantitative data. Planned analysis will be by intention to treat (quantitative data) and thematic analysis (qualitative data)DiscussionThe trial will evaluate the effectiveness of a walking programme and a supervised general exercise programme compared to usual physiotherapy in people with CLBP.Trial registration: Current controlled trial ISRCTN17592092</description>
        <link>http://www.biomedcentral.com/1471-2474/10/79</link>
                <dc:creator>Deirdre Hurley</dc:creator>
                <dc:creator>Grainne O'Donoghue</dc:creator>
                <dc:creator>Mark Tully</dc:creator>
                <dc:creator>Jennifer Klaber Moffett</dc:creator>
                <dc:creator>Willem van Mechelen</dc:creator>
                <dc:creator>Leslie Daly</dc:creator>
                <dc:creator>Colin Boreham</dc:creator>
                <dc:creator>Suzanne McDonough</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2009, 10:79</dc:source>
        <dc:date>2009-07-02T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-10-79</dc:identifier>
        <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>79</prism:startingPage>
        <prism:publicationDate>2009-07-02T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/10/78">
        <title>Central motor control failure in fibromyalgia: a surface electromyography study</title>
        <description>Background:
Fibromyalgia (FM) is characterised by diffuse musculoskeletal pain and stiffness at multiple sites, tender points in characteristic locations, and the frequent presence of symptoms such as fatigue. The aim of this study was to assess whether the myoelectrical manifestations of fatigue in patients affected by FM are central or peripheral in origin.
Methods:
Eight female patients aged 55.6+/-13.6 years (FM group) and eight healthy female volunteers aged 50.3+/-9.3 years (MCG) were studied by means of non-invasive surface electromyography (s-EMG) involving a linear array of 16 electrodes placed on the skin overlying the biceps brachii muscle, with muscle fatigue being evoked by means of voluntary and involuntary (electrically elicited) contractions. Maximal voluntary contractions (MVCs), motor unit action potential conduction velocity distributions (mean+/-SD and skewness), and the mean power frequency of the spectrum (MNF) were estimated in order to assess whether there were any significant differences between the two groups and contraction types.
Results:
The motor pattern of recruitment during voluntary contractions was altered in the FM patients, who also showed fewer myoelectrical manifestations of fatigue (normalised conduction velocity rate of changes: -0.074+/-0.052%/s in FM vs -0.196+/-0.133 %/s in MCG; normalised MNF rate of changes: -0.29+/-0.16%/s in FM vs -0.66+/-0.34%/s in MCG). Mean conduction velocity distribution and skewnesses values were higher (p&lt;0.01) in the FM group. There were no between-group differences in the results obtained from the electrically elicited contractions.
Conclusion:
The apparent paradox of fewer myoelectrical manifestations of fatigue in FM is the electrophysiological expression of muscle remodelling in terms of the prevalence of slow conducting fatigue-resistant type I fibres. As the only between-group differences concerned voluntary contractions, they are probably more related to central motor control failure than muscle membrane alterations, which suggests pathological muscle fibre remodelling related to altered suprasegmental control.</description>
        <link>http://www.biomedcentral.com/1471-2474/10/78</link>
                <dc:creator>Roberto Casale</dc:creator>
                <dc:creator>Piercarlo Sarzi-Puttini</dc:creator>
                <dc:creator>Fabiola Atzeni</dc:creator>
                <dc:creator>Marco Gazzoni</dc:creator>
                <dc:creator>Dan Buskila</dc:creator>
                <dc:creator>Alberto Rainoldi</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2009, 10:78</dc:source>
        <dc:date>2009-07-01T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-10-78</dc:identifier>
        <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>78</prism:startingPage>
        <prism:publicationDate>2009-07-01T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/10/77">
        <title>Thoracic spine pain in the general population: Prevalence, incidence and associated factors in children, adolescents and adults. A systematic review
</title>
        <description>Background:
Thoracic spine pain (TSP) is experienced across the lifespan by healthy individuals and is a common presentation in primary healthcare clinical practice. However, the epidemiological characteristics of TSP are not well documented compared to neck and low back pain. A rigorous evaluation of the prevalence, incidence, correlates and risk factors needs to be undertaken in order for epidemiologic data to be meaningfully used to develop evidence-based prevention and treatment recommendations for TSP.
Methods:
A systematic review method was followed to report the evidence describing prevalence, incidence, associated factors and risk factors for TSP among the general population. Nine electronic databases were systematically searched to identify studies that reported either prevalence, incidence, associated factors (cross-sectional study) or risk factors (prospective study) for TSP in healthy children, adolescents or adults. Studies were evaluated for level of evidence and method quality.
Results:
Of the 1389 studies identified in the literature, 33 met the inclusion criteria for this systematic review.  The mean (SD) quality score (out of 15) for the included studies was 10.5 (2.0). TSP prevalence data ranged from 4.0-72.0% (point), 0.5-51.4% (7-day), 1.4-34.8% (1-month), 4.8-7.0% (3-month), 3.5-34.8% (1-year) and 15.6-19.5% (lifetime). TSP prevalence varied according to the operational definition of TSP. Prevalence for any TSP ranged from 0.5-23.0%, 15.8-34.8%, 15.0-27.5% and 12.0-31.2% for 7-day, 1-month, 1-year and lifetime periods, respectively. TSP associated with backpack use varied from 6.0-72.0% and 22.9-51.4% for point and 7-day periods, respectively. TSP interfering with school or leisure ranged from 3.5-9.7% for 1-year prevalence. Generally, studies reported a higher prevalence for TSP in child and adolescent populations, and particularly for females. The 1 month, 6 month, 1 year and 25 year incidences were 0-0.9%, 10.3%, 3.8-35.3% and 9.8% respectively. TSP was significantly associated with: concurrent musculoskeletal pain; growth and physical; lifestyle and social; backpack; postural; psychological; and environmental factors. Risk factors identified for TSP in adolescents included age (being older) and poorer mental health.
Conclusions:
TSP is a common condition in the general population. While there is some evidence for biopsychosocial associations it is limited and further prospectively designed research is required to inform prevention and management strategies.</description>
        <link>http://www.biomedcentral.com/1471-2474/10/77</link>
                <dc:creator>Andrew Briggs</dc:creator>
                <dc:creator>Anne Smith</dc:creator>
                <dc:creator>Leon Straker</dc:creator>
                <dc:creator>Peter Bragge</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2009, 10:77</dc:source>
        <dc:date>2009-06-29T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-10-77</dc:identifier>
        <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>77</prism:startingPage>
        <prism:publicationDate>2009-06-29T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/10/76">
        <title>Optimising corticosteroid injection for lateral epicondylalgia with the addition of physiotherapy: A protocol for a randomised control trial with placebo comparison.</title>
        <description>Background:
Corticosteroid injection and physiotherapy are two commonly prescribed interventions for management of lateral epicondylalgia. Corticosteroid injections are the most clinically efficacious in the short term but are associated with high recurrence rates and delayed recovery, while physiotherapy is similar to injections at 6 weeks but with significantly lower recurrence rates. Whilst practitioners frequently recommend combining physiotherapy and injection to overcome harmful effects and improve outcomes, study of the benefits of this combination of treatments is lacking. Clinicians are also faced with the paradox that the powerful anti-inflammatory corticosteroid injections work well, albeit in the short term, for a non-inflammatory condition like lateral epicondylalgia. Surprisingly, these injections have not been rigorously tested against placebo injections. This study primarily addresses both of these issues.
Methods:
A randomised placebo-controlled clinical trial with a 2 &#215; 2 factorial design will evaluate the clinical efficacy, cost-effectiveness and recurrence rates of adding physiotherapy to an injection. In addition, the clinical efficacy and adverse effects of corticosteroid injection beyond that of a placebo saline injection will be studied. 132 participants with a diagnosis of lateral epicondylalgia will be randomly assigned by concealed allocation to one of four treatment groups &#8211; corticosteroid injection, saline injection, corticosteroid injection with physiotherapy or saline injection with physiotherapy. Physiotherapy will comprise 8 sessions of elbow manipulation and exercise over an 8 week period. Blinded follow-up assessments will be conducted at baseline, 4, 8, 12, 26 and 52 weeks after randomisation. The primary outcome will be a participant rating of global improvement, from which measures of success and recurrence will be derived. Analyses will be conducted on an intention-to-treat basis using linear mixed and logistic regression models. Healthcare costs will be collected from a societal perspective, and along with willingness-to-pay and quality of life data will facilitate cost-effectiveness and cost-benefit analyses.
Conclusion:
This trial will utilise high quality trial methodologies in accordance with CONSORT guidelines. Findings from this study will assist in the development of evidence based practice recommendations and potentially the optimisation of resource allocation for rehabilitating lateral epicondylalgia.Trial registrationAustralian New Zealand Clinical Trials Register ACTRN12609000051246</description>
        <link>http://www.biomedcentral.com/1471-2474/10/76</link>
                <dc:creator>Brooke Coombes</dc:creator>
                <dc:creator>Leanne Bisset</dc:creator>
                <dc:creator>Luke Connelly</dc:creator>
                <dc:creator>Peter Brooks</dc:creator>
                <dc:creator>Bill Vicenzino</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2009, 10:76</dc:source>
        <dc:date>2009-06-24T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-10-76</dc:identifier>
        <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>76</prism:startingPage>
        <prism:publicationDate>2009-06-24T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/10/75">
        <title>Study protocol
Preventing knee injuries in adolescent female football players - design of a cluster randomized controlled trial [NCT00894595]
</title>
        <description>Background:
Knee injuries in football are common regardless of age, gender or playing level, but adolescent females seem to have the highest risk. The consequences after severe knee injury, for example anterior cruciate ligament (ACL) injury, are well-known, but less is known about knee injury prevention. We have designed a cluster randomized controlled trial (RCT) to evaluate the effect of a warm-up program aimed at preventing acute knee injury in adolescent female football.
Methods:
In this cluster randomized trial 516 teams (309 clusters) in eight regional football districts in Sweden with female players aged 13-17 years were randomized into an intervention group (260 teams) or a control group (256 teams). The teams in the intervention group were instructed to do a structured warm-up program at two training sessions per week throughout the 2009 competitive season (April to October) and those in the control group were informed to train and play as usual. Sixty-eight sports physical therapists are assigned to the clubs to assist both groups in data collection and to examine the players&apos; acute knee injuries during the study period. Three different forms are used in the trial: (1) baseline player data form collected at the start of the trial, (2) computer-based registration form collected every month, on which one of the coaches/team leaders documents individual player exposure, and (3) injury report form on which the study therapists report acute knee injuries resulting in time loss from training or match play. The primary outcome is the incidence of ACL injury and the secondary outcomes are the incidence of any acute knee injury (except contusion) and incidence of severe knee injury (defined as injury resulting in absence of more than 4 weeks). Outcome measures are assessed after the end of the 2009 season.DiscussionPrevention of knee injury is beneficial for players, clubs, insurance companies, and society. If the warm-up program is proven to be effective in reducing the incidence of knee injury, it can have a major impact by reducing the future knee injury burden in female football as well as the negative long-term disabilities associated with knee injury.Trial registration: NCT00894595</description>
        <link>http://www.biomedcentral.com/1471-2474/10/75</link>
                <dc:creator>Martin Hagglund</dc:creator>
                <dc:creator>Markus Walden</dc:creator>
                <dc:creator>Isam Atroshi</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2009, 10:75</dc:source>
        <dc:date>2009-06-23T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-10-75</dc:identifier>
        <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>75</prism:startingPage>
        <prism:publicationDate>2009-06-23T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2474/10/74">
        <title>A survey of referee participation, training and injury in elite gaelic games referees</title>
        <description>Background:
Referees in Gaelic games are exposed to injury risk in match-play and training. Little is currently know about the degree of exposure or the prevalence of injury in this group. The aim of this study was to determine the time commitment to refereeing and training in elite-level Gaelic referees and to establish, for the first time, point and period (past 12 months) prevalence of Gaelic games injury in these officials.
Methods:
A retrospective survey was posted to the complete list of 111 male referees who officiated in elite-level competition in Gaelic football and hurling at the end of the 2005 competition season.  Data were summarised using percentages with 95% Confidence Intervals.
Results:
The response rate was 80% (n=89).  Mean age was 42+/-6 years, ranging from 28-55 years.  Forty eight percent were football referees, 25% were hurling referees and 27% refereed both football and hurling.  Most referees (69%) officiated at 3-4 games weekly (range 1-6) and most (62%) trained 2-3 times per week (range 1-7). Fourteen percent (n=12) were currently injured (95% CI 9-21%).  Annual injury prevalence was 58% (95% CI 46 to 70%) for football, 50% (95% CI 33 to 67%) for hurling and 42% (95% CI 27 to 58%) for dual referee groups.  Sixty percent of injuries were sustained while refereeing match play. The majority (83%, n=40) were to the lower limb and the predominant (56%, n=27) injury mechanism was running or sprinting.  The most prevalent injuries were hamstring strain (n=12, 25% of injuries) and calf strain (n=9, 19% of injuries).  Injury causing time off from refereeing was reported by 31% of all referees (95% CI 24 to 40%, n=28), for a median duration of 3 weeks.
Conclusions:
Participation in official duties and training is high in elite Gaelic games referees, despite the amateur status of the sports.  Gaelic games injury is common in the referee cohort, with lower limb injury predominating.  These injuries have implications for both the referee and for organisation of the games.</description>
        <link>http://www.biomedcentral.com/1471-2474/10/74</link>
                <dc:creator>Catherine Blake</dc:creator>
                <dc:creator>James Sherry</dc:creator>
                <dc:creator>Conor Gissane</dc:creator>
                <dc:source>BMC Musculoskeletal Disorders 2009, 10:74</dc:source>
        <dc:date>2009-06-22T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2474-10-74</dc:identifier>
        <prism:publicationName>BMC Musculoskeletal Disorders</prism:publicationName>
        <prism:issn>1471-2474</prism:issn>
        <prism:volume>10</prism:volume>
        <prism:startingPage>74</prism:startingPage>
        <prism:publicationDate>2009-06-22T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
